KONE Corporation, stock exchange release, January 30, 2025 at 08:00 p.m. EET. KONE Corporation: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10. KONE C ...

On 30 January 2025, the Board of Directors of Oma Savings Bank Plc (OmaSp or the Company) has reorganised in terms of the Vice Chairperson and the Committees. The Board of Directors has elected Carl ...

ORION CORPORATION PRESS RELEASE 30 JANUARY 2025 at 16.00 EET . Orion and Invenra announce discovery service and commercial license agreement to develop innovative bispecific antib ...

Wärtsilä Corporation, Stock exchange release, 30 January 2025 at 16:00 EET. Proposals of the Shareholders' Nomination Board to Wärtsilä's Annual General Meeting 2025. The Shar ...

Nokia Corporation Stock Exchange Release 30 January 2025 at 8:10 EET. Proposals by the Board of Directors to Nokia Corporation’s Annual General Meeting 2025 Nokia Corporation’ ...

The Board of Directors of KONE Corporation has on 29 January 2025 decided on commencement of a performance based long-term incentive plan 2025-2027 and Restricted Share Plan 2025 under the long-term ...

On 30 January 2025, the World Health Organization (WHO) announced that Niger has been verified for eliminating the transmission of onchocerciasis, commonly known as river blindness. The Mectizan ...

ALK (ALKB:DC / OMX: ALK B / AKBLF) today announced that the National Institute for Health and Care Excellence (NICE) has recommended the use of ACARIZAX® for the treatment of persistent, moderate to ...

SPEE3D, a leading metal additive manufacturing company, announced it has sold a WARPSPEE3D printer to Northeastern University and the school's Kostas Research Institute (KRI) in Burlington, ...

The Shareholders' Nomination Board of Bioretec Ltd ("Bioretec") has resolved to make the following proposals to the Annual General Meeting. The Annual General Meeting of Bioretec is scheduled to be ...

Toivo Group Plc (”Toivo”) has published a new owner-occupied housing project to Vantaa’s Vapaala. The value of the project is approximately EUR 2,5 million and it includes a total of six family sized ...

Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat ...